Cargando…
Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation
The new coronavirus SARS-COV-2, which emerged in late 2019 from Wuhan city of China was regarded as causing agent of the COVID-19 pandemic. The primary protease which is also known by various synonymous i.e., main protease, 3-Chymotrypsin-like protease (3CL(PRO)) has a vital role in the replication...
Autores principales: | Samad, Abdus, Ajmal, Amar, Mahmood, Arif, Khurshid, Beenish, Li, Ping, Jan, Syed Mansoor, Rehman, Ashfaq Ur, He, Pei, Abdalla, Ashraf N., Umair, Muhammad, Hu, Junjian, Wadood, Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028080/ https://www.ncbi.nlm.nih.gov/pubmed/36959979 http://dx.doi.org/10.3389/fmolb.2023.1060076 |
Ejemplares similares
-
New drug target identification in Vibrio vulnificus by subtractive genome analysis and their inhibitors through molecular docking and molecular dynamics simulations
por: Alotaibi, Bader S., et al.
Publicado: (2023) -
A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach
por: Riaz, Muhammad, et al.
Publicado: (2023) -
Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus
por: Ajmal, Amar, et al.
Publicado: (2023) -
Toward the Noninvasive Diagnosis of Alzheimer’s
Disease: Molecular Basis for the Specificity of Curcumin for Fibrillar
Amyloid-β
por: Khurshid, Beenish, et al.
Publicado: (2022) -
Molecular Dynamic Simulation Analysis of a Novel Missense Variant in CYB5R3 Gene in Patients with Methemoglobinemia
por: Ullah, Asmat, et al.
Publicado: (2023)